| Number |
CAGE |
FSC |
NIIN |
Item Name |
RN CC |
RN VC |
ISC |
|
0356-10 |
25282 |
6505 |
01-268-9154
|
TESTOSTERONE ENANTHATE INJECTION |
3 |
2 |
5 |
|
649290 |
25282 |
6220 |
00-402-7317
|
HEADLIGHT |
5 |
2 |
2 |
|
85-778 |
25282 |
6505 |
01-176-7602
|
HYDROXYZINE HYDROCHLORIDE INJECTION |
5 |
1 |
5 |
|
METHOCARBAMOL INJECTION |
25282 |
6505 |
00-754-0395
|
METHOCARBAMOL INJECTION |
3 |
1 |
2 |
|
NDC00381-0042-05 |
25282 |
6505 |
01-211-6815
|
TRIAMCINOLONE DIACETATE INJECTABLE SUSPENSION |
5 |
9 |
5 |
|
NDC00381-0077-10 |
25282 |
6505 |
01-213-2670
|
PYRIDOXINE HYDR |
3 |
2 |
* |
|
NDC00381-0077-10 |
25282 |
6505 |
01-153-4053
|
PYRIDOXINE HYDROCHLORIDE INJECTION |
3 |
2 |
2 |
|
NDC00381-0085-30 |
25282 |
6505 |
00-063-5606
|
THIAMINE HYDROCHLORIDE INJECTION |
3 |
2 |
2 |
|
NDC00381-0096-30 |
25282 |
6505 |
01-216-1825
|
MAGNESIUM SULFATE INJECTION |
3 |
2 |
5 |
|
NDC00381-0170-10 |
25282 |
6505 |
01-176-7602
|
HYDROXYZINE HYDROCHLORIDE INJECTION |
3 |
2 |
5 |
|
NDC00381-0171-10 |
25282 |
6505 |
01-178-3945
|
HYDROXYZINE HYDROCHLORIDE INJECTION |
3 |
2 |
5 |
|
NDC00381-0204-05 |
25282 |
6505 |
01-211-2392
|
TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION |
5 |
9 |
5 |
|
NDC00381-0243-05 |
25282 |
6505 |
01-131-5620
|
MULTIVITAMIN SOLUTION FOR INJECTION |
3 |
1 |
5 |
|
NDC00381-0243-05 |
25282 |
6505 |
01-135-2096
|
MULTIVITAMIN SOLUTION FOR INJECTION |
3 |
1 |
5 |
|
►NDC00381-0261-10 |
25282 |
6505 |
00-684-8666
|
CHLORPROMAZINE HYDROCHLORIDE INJECTION |
3 |
2 |
5 |
|
NDC00381-0424-02 |
25282 |
6505 |
01-216-4953
|
NONDROLONE PHENPROPIONATE INJECTION,USP |
3 |
2 |
5 |
|
NDC00381-0464-10 |
25282 |
6505 |
00-299-8614
|
PROCAINAMIDE HYDROCHLORIDE INJECTION |
3 |
2 |
2 |
|
NDC00402-0356-10 |
25282 |
6505 |
01-207-8246
|
TESTOSTERONE ENANTHATE INJECTION |
3 |
1 |
2 |
|
NDC00402-0356-10 |
25282 |
6505 |
01-268-9154
|
TESTOSTERONE ENANTHATE INJECTION |
3 |
2 |
5 |
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|